Encoded Therapeutics Inc.
Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.
$275MSeries F
ParticipantRI
RTW Investments
Activity from announced rounds
Activity in this selectionOct 18, 2026 · Jul 21, 2026
RTW Investments is the investment manager named in Amani and Encoded financing histories.
Recorded funding activity
Amani develops combination medicines for neuropsychiatric disorders. Encoded develops gene-regulation therapies for neurological disease. The histories refer to the manager rather than a specified RTW fund.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $275M 1 disclosed · full round size, not this investor’s share